Physician profile
Allison Moore
NPI 1033453428
$2,345.23
in general payments reported to CMS, 2019-2025
16 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $580 · 2023: $787 · 2024: $95.49 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,552.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $871.98 | 2021-2025 | Farxiga, Breztri |
| Lilly USA, LLC | $481.75 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $390.53 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Tandem Diabetes Care, INC. | $195.79 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Sequel Med Tech, LLC | $101.75 | 2025 | Twiist |
| Beta Bionics, INC. | $55.08 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Xeris Pharmaceuticals, INC. | $46.34 | 2024-2025 | Recorlev |
| Amgen INC. | $39.33 | 2025 | Repatha, Otezla |
| Inspire Medical Systems, INC. | $29.32 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $29.02 | 2023 | Trintellix |
| Glaxosmithkline, LLC. | $23.69 | 2025 | Penmenvy, Bexsero, Rotarix |
| Biogen, INC. | $20.73 | 2025 | Zurzuvae |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.68 | 2025 | Jardiance |
| Medtronic, INC. | $15.59 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.36 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.29 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.